Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Topical Vitiligo Therapeutics
The 2025-2030 World Outlook for Topical Vitiligo Therapeutics This study covers the world outlook for topical vitiligo therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Aneurysmal Subarachnoid Hemorrhage Drugs
The 2025-2030 World Outlook for Aneurysmal Subarachnoid Hemorrhage Drugs This study covers the world outlook for aneurysmal subarachnoid hemorrhage drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Topical Pigmentation Disorders Treatment Drugs
The 2025-2030 World Outlook for Topical Pigmentation Disorders Treatment Drugs This study covers the world outlook for topical pigmentation disorders treatment drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for Angina Pectoris Drugs
The 2025-2030 World Outlook for Angina Pectoris Drugs This study covers the world outlook for angina pectoris drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Thin Film Drugs
The 2025-2030 World Outlook for Thin Film Drugs This study covers the world outlook for thin film drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Primary Focal Segmental Glomerulosclerosis
The 2025-2030 World Outlook for Primary Focal Segmental Glomerulosclerosis This study covers the world outlook for primary focal segmental glomerulosclerosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Ophthalmic Disease Therapeutics
The 2025-2030 World Outlook for Ophthalmic Disease Therapeutics This study covers the world outlook for ophthalmic disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Erectile Dysfunction Therapeutics
The 2025-2030 World Outlook for Erectile Dysfunction Therapeutics This study covers the world outlook for erectile dysfunction therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Pain Therapeutics
The 2025-2030 World Outlook for Pain Therapeutics This study covers the world outlook for pain therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Rare Endocrine Disease Treatments
The 2025-2030 World Outlook for Rare Endocrine Disease Treatments This study covers the world outlook for rare endocrine disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Drugs
The 2025-2030 World Outlook for Liver Cancer Drugs This study covers the world outlook for liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Critical Care Therapeutics
The 2025-2030 World Outlook for Critical Care Therapeutics This study covers the world outlook for critical care therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Epilepsy Treatments
The 2025-2030 World Outlook for Epilepsy Treatments This study covers the world outlook for epilepsy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Crohn's Disease Therapeutics
The 2025-2030 World Outlook for Crohn's Disease Therapeutics This study covers the world outlook for Crohn's disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics
The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics This study covers the world outlook for psoriatic arthritis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes This study covers the world outlook for intravenous immunoglobulin for guillain-Barre syndromes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Mutation-Suppression Duchenne Muscular Dystrophy Drugs
The 2025-2030 World Outlook for Mutation-Suppression Duchenne Muscular Dystrophy Drugs This study covers the world outlook for mutation-suppression Duchenne muscular dystrophy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Myasthenia Gravis Drugs
The 2025-2030 World Outlook for Myasthenia Gravis Drugs This study covers the world outlook for myasthenia gravis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Myeloproliferative Disorder Drugs
The 2025-2030 World Outlook for Myeloproliferative Disorder Drugs This study covers the world outlook for myeloproliferative disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for HIV Therapeutics
The 2025-2030 World Outlook for HIV Therapeutics This study covers the world outlook for HIV therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Mouth Ulcer Drugs
The 2025-2030 World Outlook for Mouth Ulcer Drugs This study covers the world outlook for mouth ulcer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma Treatments
The 2025-2030 World Outlook for Multiple Myeloma Treatments This study covers the world outlook for multiple myeloma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Respiratory Drugs
The 2025-2030 World Outlook for Respiratory Drugs This study covers the world outlook for respiratory drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Drugs
The 2025-2030 World Outlook for Multiple Sclerosis Drugs This study covers the world outlook for multiple sclerosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Photodynamic Therapies
The 2025-2030 World Outlook for Photodynamic Therapies This study covers the world outlook for photodynamic therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
Research Assistance
